CARMEL, Ind., Feb. 27, 2018 -- Determine, Inc. (NASDAQ:DTRM), a pioneering leader in global Source-to-Pay and Enterprise Contract Lifecycle Management (ECLM) Cloud Platform solutions, announced today that the company has successfully met the requirements to comply with the Health Insurance Portability and Accountability Act (HIPAA) and Health Information Technology for Economic and Clinical Health (HITECH) Act, as examined by an independent third party, Schellman & Company. The HIPAA Compliance Program demonstrates Determine's ongoing commitment to healthcare organizations and increasing customer confidence.
The HIPAA Privacy and Security Rules set forth stringent requirements for safeguarding personal health information. The U.S. Department of Health & Human Services oversees and enforces these regulations to protect individuals’ medical records and other personal health information which apply to health plans, health care clearinghouses, and health care providers that conduct certain health care transactions electronically.
“Our HIPAA Compliance Program further establishes Determine as an industry-leading cloud platform for healthcare organizations. But we recognize that compliance with the requirements of the HIPAA is a process, not a one-off event. We are committed to maintaining and improving our compliance activities regularly, with independent examination and verification to support these accomplishments. As a premier provider of technology services and expertise to the healthcare industry, handling all sensitive data with the utmost regard for privacy and security is our first priority. For our large and growing base of healthcare customers, they can have full confidence in knowing that Determine is looking out for their best interests, and those of their patients, by fulfilling our responsibilities to data privacy and protection in every way we can.”
— Patrick Stakenas, President, CEO and Director, Determine, Inc.
Determine’s compliance with HIPAA and HITECH requirements, examined by independent compliance audit firm Schellman & Company, assures healthcare organizations that they can work with Determine as a Business Associate. Along with Determine’s SOC 2 attestation, compliance with the HIPAA rules reflects Determine’s commitment to providing the highest levels of security in SaaS Source-to-Pay and Enterprise Contract Lifecycle Management for the most demanding and regulated industries, including healthcare.
About Schellman & Company
Schellman & Company is a trusted provider to the world’s leading companies, from the Fortune 1000 and publicly traded companies, to privately held entities of all sizes, with a service delivery model that allows for optimum quality and client experience for organizations of every size and complexity.
Supporting Resources
Determine blog
Determine on LinkedIn
Determine on Twitter
Determine Resources
About Determine, Inc.
Determine, Inc. (NASDAQ:DTRM) is a leading global provider of SaaS Source-to-Pay and Enterprise Contract Lifecycle Management (ECLM) solutions. The Determine Cloud Platform provides procurement, legal and finance professionals analytics of their supplier, contract and financial performance. Our technologies empower customers to drive new revenue, identify savings, improve compliance and mitigate risk.
The Determine Cloud Platform seamlessly integrates with major ERP or third-party systems such as SAP, Oracle, Sage, QAD and Microsoft. Modular solutions can be configured to add more as needed to provide additional value beyond spend management. Our unified master database and business process approach empower users at every level to make more informed and smarter decisions.
For more information, please visit: http://www.determine.com/.
Contact
Media Relations:
Mike Mitchell
Determine Inc.
+1.650.532.1590
[email protected]


DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
OpenAI Restricts Astra AI Over Cyberattack Risks
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 



